NLRP3 inflammasome as a novel therapeutic target for Alzheimer's disease

Signal Transduct Target Ther. 2020 Apr 1;5(1):37. doi: 10.1038/s41392-020-0145-7.
No abstract available

Publication types

  • Comment

MeSH terms

  • Alzheimer Disease* / drug therapy
  • Amyloid beta-Peptides
  • Caspase 1
  • Humans
  • Inflammasomes*
  • NLR Family, Pyrin Domain-Containing 3 Protein / genetics

Substances

  • Amyloid beta-Peptides
  • Inflammasomes
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Caspase 1